![](/img/cover-not-exists.png)
ESPAC-5F: Four arm, international randomised phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer
Ghaneh, P., Palmer, D., Cicconi, S., Halloran, C., Psarelli, E., Rawcliffe, C., Sripadam, R., Mukherjee, S., Wadsley, J., Al-Mukhtar, A., Jiao, L., Wasan, H., Carter, R., Graham, J., Ammad, F., Evans,Volume:
20
Journal:
Pancreatology
DOI:
10.1016/j.pan.2020.07.370
Date:
November, 2020
File:
PDF, 454 KB
2020